Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 3Recurrence 2Urologic Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Leukemia, Hairy Cell 1Colonic Neoplasms 1

Interventions

sargramostim 1immunotoxin HA22 1Therapeutics 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Levofloxacin 1Ketamine 1Indium 1Ifosfamide 1Flow Cytometry 1Filgrastim 1Etoposide 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Cefepime 1Carboplatin 1Biological Therapy 1Analgesia 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Hairy Cell × Biological Therapy × Clear all
NCT00462189 2007-04-18

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Cambridge Antibody Technology

Phase 1 Unknown
40 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡